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To the Editor: 
Inherited hair loss can follow both Mendelian and complex patterns of inheritance. Alopecia areata 
is a nonscarring form of hair loss with a prevalence of 0.1%-0.2% in the USA (Safavi, 1992). Its 
most severe form, alopecia universalis (AU) leads to total hair loss from the whole body. Alopecia 
areata is inherited as a complex genetic trait in which coinheritance of more than one gene is 
believed to confer susceptibility to the phenotype. In contrast, atrichia with papular lesions (APL) 
(OMIM#209500) is an autosomal recessive Mendelian disorder characterized by the onset of 
complete alopecia during infancy (Zlotogorski et al, 2002b), leading to its misdiagnosis as AU. 
Although the genetic basis of alopecia areata remains unknown, APL results from mutations in a 
single gene, hairless (HR). 
The differentiation between AU and APL is of extreme importance. Although many patients with 
AU respond to available therapies, APL patients fail to respond to any treatment modality over 
several years, which eventually leads to the diagnosis of APL. The final proof, however, is based 
upon identification of mutations in the HR gene. To date, these mutations have all (with one 
exception) been homozygous mutations in APL patients from consanguineous families (Ahmadet 
al, 1998; Cichon et al, 1998; Zlotogorski et al, 1998; Henn et al, 2002). 
The increasing number of reports of patients with APL (Ahmad et al, 1999a; 1999b; Kruse et al, 
1999; Sprecher et al, 1999; Aita et al, 2000; Zlotogorski et al, 2002a) led us to hypothesize that 
APL is much more common than previously considered and in some cases is misdiagnosed as AU. 
This misdiagnosis is most probably due to lack of awareness, lack of fixed diagnostic criteria until 
recently (Zlotogorski et al, 2002b), and the belief that patients with APL are found only rarely and 
in consanguineous families. 
In this study, we identified three small nonconsanguineous families with only one offspring affected 
by early onset hair loss that never regrew. Importantly, these patients either had an associated 
papular eruption and/or failed to respond to treatment for AU. Upon examination, the clinical 
findings in all three families were consistent with APL. 
The proband in family A is a 22-y-old woman (Figure 1a). Her father and mother originate from 
Iraq and Morocco, respectively. The proband denied any history of consanguinity. The patient was 
born with few hairs that were shed during the first months of life. Topical treatments failed to 
induce hair regrowth. Papules appeared at 3 y of age on the scalp, cheeks, arms, and shins. The 
number of nonfacial papules has steadily declined with time. On examination, we observed 
complete scalp atrichia, absence of body hair, and sparse eyebrows and eyelashes. She had 
numerous papules on the arms, thighs, elbows (Figure 2a, b), knees, lower neck, and back. A few 
papules were present on the scalp, as well as hypopigmented marks. 
The proband in family B is a 4-y-old boy who was adopted by his family at the age of 19 mo from 
Russia, and had complete alopecia at that time. The patient was presumed to have AU, and was 
treated with class II topical corticosteroids, topical 2% minoxidil, short contact anthralin, and 
squaric acid dibutylester immunotherapies, but no hair was generated. Examination showed atrichia 
of the entire scalp, sparse thin eyelashes and eyebrows, a 2.5 mm papule on the elbow, and no 
hypopigmented patches. Nails and dentition were normal. 
Finally, the proband in family C is a 13-mo-old boy (II-3). Both parents are Australian of English 
descent and denied any history of consanguinity. The proband was born with only four strands of 
hair on his head that fell out within 10 d and failed to regrow. He had no eyebrows at birth and had 
only a few eyelashes. A papular eruption appeared on the arms and legs at 3mo of age and eruptions 
gradually increased in number until 12 mo of age. Examination showed scalp atrichia (Figure 2c) 
with only a single strand of blonde hair on the vertex. He had scattered eyebrows and sparse 
eyelashes (Figure 2d). Papules were noted on the arms, thighs, and lower legs. Teeth, nails, and 
sweating were normal. 
To screen for mutations in the HR gene, all exons and splice junctions were PCR amplified 
(Ahmad et al, 1999b) in the patients and their relatives. The proband in family A was found to carry 
a maternally derived C-to-T transition in exon 4 resulting in the nonsense mutation Q478X, and a 
paternally derived G-to-T transversion at the acceptor splice site of intron 4, 1557–1G  T (Figure 
1a). 
The proband in family B carried a previously described T-to-G transversion at nucleotide position 
1864 within exon 6, resulting in the missense mutation C622G, and a C-to-G transversion at 
position –3 at the acceptor splice site of intron 13, 2847–3C  G (Figure 1b). 
Finally, the proband from family C was a compound heterozygote for the maternally derived 
nonsense mutation Q478X, identical to that in family A, and a paternally derived T insertion at 
position +2 at the splice donor site of intron 12, 2776 + 2insT (Figure 1c). 
We tested 40–83 control individuals (80–166 alleles) for the presence of these mutations, to rule out 
the unlikely possibility that they were polymorphisms. The absence of these mutations in the 
control chromosomes, the nature and severity of the mutations, and the recurrence of some of them 
in unrelated probands provide evidence that they represent the pathogenetic mutations in these 
families. 
In summary, we have identified compound heterozygous mutations in the HR gene in three 
individuals. The type of hair and papular involvement were not different from those seen in patients 
carrying homozygous mutations. 
The nonsense mutation Q478X was first described in a consanguineous Pakistani family 
(Sprecher et al, 1999). Here, we find the same mutation recurring in two unrelated individuals of 
Moroccan and Australian origin. The occurrence of this mutation on such diverse backgrounds 
suggests that Q478X may represent a mutational hotspot. 
A second recurrent mutation was the missense C622G, previously identified in a consanguineous 
family of Polish descent (Aita et al, 2000). The mutation alters the third of four invariant cysteine 
residues in the zinc-finger domain, with high homology to the C-X-X-C-(X)17-C-X-X-C structure 
of the zinc fingers of the GATA family of transcription factors. 
Finally, we identified splice site mutations in each proband, 1557–1G  T (family A), 2847–3C 
 G (family B), and 2776 +2insT (family C). As mRNA samples from the patients were not 
available, we calculated the splicing efficiency score for all of them (Shapiro and Senapathy, 1987). 
The mutation in family A is predicted to abolish normal splicing of exon 5 on this allele, as the 
invariant AG immediately preceding the exon is changed to AT. The scores for the wild-type and 
mutant sequences are 89.13 and 73.11, respectively. In family B, the mutation 2847–3C  G results 
in the splice site change from ccctaccctgaCag/exon to ccctaccctgaGag/exon and a reduction in the 
score from 90.00 to 78.30. Finally, the mutation 2776 + 2insT in family C changes the consensus 
sequence from exon/gtaagt to exon/gtTaag, with scores of 78.65 and 49.64, respectively. 
Furthermore, identification of HR mutations in the proband in family B excludes the possibility of 
an alternative autosomal recessive form of hypotrichosis, specific to the Mari population in the 
Volga-Ural region of Russia. Affected individuals with Mari hypotrichosis have sparse scalp hairs 
that are wiry and twisted. The eyelashes and eyebrows are shed after the first year of life and remain 
absent. Body hair is generally sparse and thin, and axillary and pubic hair is essentially absent. 
Mutations in the HR gene have recently been excluded in 21 families (Rogaev et al, 1999). 
Prior to this study, only one APL patient with compound heterozygous mutations had been 
described in a small nonconsanguineous family (Henn et al, 2002). Three additional compound 
heterozygous patients from families without consanguinity further support the hypothesis that 
isolated cases of APL may be more common than previously thought. 
These data extend our knowledge of mutations in the HR gene, and may suggest that infants with 
presumed AU in small nonconsanguineous families may warrent testing for HR gene mutations, 
particularly before embarking on therapeutic modalities that will fail in APL. 
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Figures 
Figure I 
 
Mutation analysis of the three families with APL. Pedigrees representing families A, B, and C with 
the proband affected with APL are shown. Note the absence of parental 
consanguinity. Circles and squares represent female and male patients, respectively. The black half-
filled figures represent mutation carriers. Automated DNA sequence analysis of the HR gene is 
shown for each mutation. (A) DNA sequence of exon 4 and intron 4 from compound heterozygous 
individual II-1 revealed the nonsense mutation Q478X on the maternal allele and the splice site 
mutation 1557–1G  T on the paternal allele (arrows). (B) DNA sequence of exon 6 and intron 13 
from the compound heterozygous individual II-1 revealed the missense mutation C622G and the 
splice site mutation 2847–3C  G (arrows). (C) Sequence analysis of exon 4 and intron 12 from the 
compound heterozygous individual II-3 demonstrated the presence of the nonsense mutation 
Q478X on the maternal allele and the splice site mutation 2776 + 2insT on the paternal allele 
(arrows). 
Figure II 
 
Clinical presentation of atrichia with papular lesions (families A and C). In patient II-1 from family 
A, there is complete atrichia, with several papules on the thighs (A) and around the elbow (B). In 
patient II-3 from family C, complete atrichia (C) with absent eyebrows and sparse eyelashes (D) are 
noted. 
